Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: Decision from different perspectives

Vaccine

Volumn 21, Issue 25-26, 2003, Pages 3982-3987

  Hsu, Hui Chun ^a   Lin, Ruey Shiung ^a   Tung, Tao Hsin ^a   Chen, Tony Hsiu Hsi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cost benefit analysis; Markov Decision Model; Varicella vaccination; Willingness to pay

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; CAPITAL; CHICKENPOX; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; DRUG COST; HEALTH CARE; HEALTH PROGRAM; HUMAN; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; REVIEW; TAIWAN; VACCINATION;

EID: 0242349114     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00270-6     Document Type: Article

References (14)

1. Coudeville L., Paree F., Lebrum T., Sailly J.C. The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. Vaccine. 17:1999;142-151.
2. Fornaro P., Gandini F., Marin M., Pedrazzi C., Piccoli P., Tognetti D.et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Pediatr. Infect. Dis. J. 18:1999;414-419.
3. Scuffham P., Devlin N., Eberhart-Philips J., Wilson-Salt R. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunization schedule. Social Sci. Med. 49:1999;763-779.
4. Beutels P., Clara R., Tormans G., Doorslaer V., Van Damme P. Costs and benefits of routine varicella vaccination in German children. J. Infect. Dis. 174(Suppl. 3):1996;S335-S341.
5. Diez Domingo J., Ridao M., Latour J., Ballester A., Morant A. A cost-benefit analysis of routine varicella vaccination in Spain. Vaccine. 17:1999;1306-1311.
6. Lieu T.A., Cochi S.L., Black S.B., Halloran M.E., Shinefield H.R., Holmes S.J.et al. Cost-effectiveness of a routine varicella vaccination program for US children. J. Am. Med. Assoc. 271:1994;375-381.
7. Sonnenberg F.A., Beck J.R. Markov models in medical decision making: a practical guide. Med. Decis. Making. 13:1993;322-338.
8. Lin Y.J., Huang L.M., Lee C.Y., Chih T.W., Lee P.L., Chang L.Y.et al. A seroepidemiological study of varicella-zoster virus in Taipei city. Acta Pediatr. Sin. 37:1996;11-15.
9. Choo P.W., Donahue J.G., Manson J.E., Platt R. The epidemiology of varicella and its complications. J. Infect. Dis. 172:1995;706-712.
10. Yawn B.P., Yawn R.A., Lydick E. Community impact of childhood varicella infections. J. Pediatr. 130:1997;759-765.
11. Huse D.M., Meissner H.C., Lacey M.J., Oster G. Childhood vaccination against chickenpox: an analysis of benefits and costs. J. Pediatr. 124:1994;869-874.
12. Hardy I, Gershon AA, Steinberg SP, LaRussa P, and the Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine. N Engl J Med 1991;325:1545-50.
13. Brunell P.A., Taylor-Wiedeman J., Geiser C.F., Frierson L., Lydick E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics. 77:1986;53-56.
14. Lawrence R, Gershon AA, Holzman R, Steinberg SP, and the NIAID Varicella Vaccine Collaborative Study Group. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988;318:543-8.